New MRI technology for safe imaging of brain stimulation devices
Reconfigurable MRI technology for safe and high-resolution imaging of deep brain stimulation at 3T
This study is working on making MRI scans safer and more effective for people with deep brain stimulation devices, like those used for Alzheimer's, so they can get better care without worrying about any risks from the MRI.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10828437 on NIH RePORTER |
What this research studies
This research focuses on improving magnetic resonance imaging (MRI) for patients with deep brain stimulation (DBS) devices, which are used to treat conditions like Alzheimer's disease. The project aims to develop innovative MRI methodologies that will allow safe imaging without the risk of harmful heating caused by the interaction between MRI and DBS leads. By creating reconfigurable MRI technology and establishing specific surgical guidelines for DBS implantation, the research seeks to enhance the compatibility of MRI with these devices, ultimately improving patient care and treatment monitoring.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with deep brain stimulation devices who are also experiencing cognitive disorders, particularly Alzheimer's disease.
Not a fit: Patients without DBS implants or those not suffering from cognitive disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enable safer and more effective imaging for patients with DBS devices, leading to better treatment outcomes.
How similar studies have performed: Other research has shown promise in developing compatible imaging techniques for patients with implanted devices, indicating that this approach has potential for success.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Golestani Rad, Laleh — Northwestern University at Chicago
- Study coordinator: Golestani Rad, Laleh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.